⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OBIO News
Orchestra BioMed Holdings, Inc. Ordinary Shares
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
globenewswire.com
OBIO
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
globenewswire.com
OBIO
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
globenewswire.com
OBIO
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
globenewswire.com
OBIO
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OBIO
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
globenewswire.com
OBIO
HAE
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
globenewswire.com
OBIO
MDT
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OBIO
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
globenewswire.com
OBIO
Orchestra BioMed to Host Business Update Call on November 12, 2025
globenewswire.com
OBIO